BLANDINO, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 6.549
EU - Europa 4.252
AS - Asia 3.089
SA - Sud America 541
AF - Africa 341
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 14.785
Nazione #
US - Stati Uniti d'America 6.264
SG - Singapore 1.674
IT - Italia 1.245
RU - Federazione Russa 1.135
CN - Cina 1.024
UA - Ucraina 784
IE - Irlanda 625
BR - Brasile 468
CI - Costa d'Avorio 272
CA - Canada 249
VN - Vietnam 136
SE - Svezia 116
GB - Regno Unito 74
DE - Germania 69
FR - Francia 58
KR - Corea 53
IN - India 41
AR - Argentina 28
PL - Polonia 27
MX - Messico 26
SN - Senegal 23
ID - Indonesia 20
BD - Bangladesh 19
CH - Svizzera 19
HK - Hong Kong 19
NL - Olanda 19
EC - Ecuador 18
AT - Austria 17
UZ - Uzbekistan 16
ZA - Sudafrica 16
IQ - Iraq 14
PK - Pakistan 13
TR - Turchia 13
CO - Colombia 11
MA - Marocco 11
ES - Italia 10
JP - Giappone 10
CZ - Repubblica Ceca 9
EU - Europa 9
GR - Grecia 9
BE - Belgio 8
FI - Finlandia 7
LB - Libano 7
EG - Egitto 6
MY - Malesia 6
IR - Iran 5
LT - Lituania 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
KE - Kenya 4
RO - Romania 4
BJ - Benin 3
BO - Bolivia 3
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
DZ - Algeria 2
HN - Honduras 2
IL - Israele 2
MD - Moldavia 2
NO - Norvegia 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BS - Bahamas 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 14.785
Città #
Dallas 1.128
Singapore 894
Santa Clara 840
Jacksonville 751
Dublin 625
Chandler 572
Moscow 459
Boardman 290
Abidjan 272
Ashburn 220
Nanjing 216
Chicago 196
Toronto 179
Lawrence 178
Andover 176
Cambridge 176
Los Angeles 174
Hefei 138
Beijing 136
San Mateo 122
Milan 89
Wilmington 88
Des Moines 83
Catania 67
Nanchang 60
Shenyang 59
Civitanova Marche 55
Hebei 52
Seoul 52
Rome 51
Jiaxing 49
Ottawa 47
Ho Chi Minh City 46
Saint Petersburg 43
Tianjin 39
Houston 34
São Paulo 34
Changsha 33
Hanoi 29
Bremen 25
Buffalo 24
Dakar 23
Columbus 21
Florence 19
The Dalles 17
Boston 16
Council Bluffs 16
New York 16
Rio de Janeiro 16
Warsaw 16
London 15
Palermo 15
Brooklyn 14
Hong Kong 14
Bologna 13
Hangzhou 13
Phoenix 13
San Jose 13
Stockholm 13
Atlanta 12
Belo Horizonte 12
Da Nang 12
Norwalk 12
Seattle 12
Verona 12
Cherasco 11
Dhaka 11
Johannesburg 11
Pune 11
Turin 11
Ann Arbor 10
Genoa 10
Montreal 10
Curitiba 9
Jinan 9
Mexico City 9
Angri 8
Brussels 8
Den Haag 8
Frankfurt Am Main 8
Kunming 8
Ribeirão Preto 8
San Francisco 8
Segrate 8
Tokyo 8
Ankara 7
Brasília 7
Chennai 7
Grafing 7
Jakarta 7
Modena 7
Mumbai 7
Orem 7
Quito 7
Washington 7
Amsterdam 6
Baghdad 6
Campinas 6
Charlotte 6
Haiphong 6
Totale 9.440
Nome #
Caratteristiche di adesione di ceppi di Bifidobacterium lactis BB-12, Bifidobacterium longum W11, Bifidobacterium bifidum su cellule epiteliali umane della linea HT-29 1.023
A novel delta-hemolysis screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-inermediate S.aureus 160
Antibiotic susceptibility profiles of uncommon bacterial species causing severe infections in Italy 151
3-Methylthio-, 3-(amino-substituted)ethylthio-, 3-carboxymethylthio-, 3,3'-(dithiobis)-5-aryl-4H(R)-1,2,4-triazoles and 2-aminomethyl-N-substituted derivatives of 5-aryl-4H(R)-1,2,4-triazolin-3-thione: synthesis and biological activity 149
Chemical and biological properties of the novel exopolysaccharide produced by a probiotic strain of Bifidobacterium longum 147
Ampliamento dello spettro di attività della vancomicina nei confronti di batteri gram-negativi mediante incapsulazione in liposomi fuso genici 130
Batteri anaerobi non sporigeni. In: MICROBIOLOGIA FARMACEUTICA 127
CARATTERISTICHE DI ADESIONE DI CEPPI DI BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BB-12, BIFIDOBACTERIUM LONGUM W11, BIFIDOBACTERIUM BIFIDUM SU CELLULE EPITELIALI UMANE DELLA LINEA HT-29 127
Impact of gut microbiota on diabetes mellitus 126
Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania 123
Antimicrobial susceptibility of Lactobacillus species used in probiotic products 121
Microbial and clinical effects of systemic flurithromycin therapy in the treatment of periodontal diseases compared with clinical procedures 118
Activity of Berberis aetnensis C. Presl. Root extract against Candida strains 117
Microbial evaluation of "in vitro" antibacterial activity of "one stage full mouth" disinfection with clorexidine in adult periodontitis 115
Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections 115
Antimicrobial susceptibility and Beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections 113
Comparison of systemic flurithromycin therapy and clinical procedures in the treatment of periodontal diseases 112
Antimicrobial susceptibility of Lactobacillus species used in probiotic products 110
BACTERIOLOGICAL STUDIES OF AMOXYCILLIN-CLAVULANIC ACID AGAINST ANEROBIC BACTERIA. 109
Microbiological and clinical periodontal effects of fixed orthodontic appliances in pediatric patients 109
Antibacterial activity of medicinal plant extracts against periodontopathic bacteria 108
In vitro inhibitory activity of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 alone or in combination against bacterial and Candida reference strains and clinical isolates 107
Antimicrobial susceptibility of Lactobacillus strains used in probiotic products 106
Antibacterial activity and post-antibiotic effect of flurithromycin compared with other macrolides and penicillins against periodontal pathogens 106
Antibiotic prescribing for dental conditions: a community-based study in southern Italy 105
Bacilli sporigeni aerobi e anaerobi (cap. 37) 105
Bacilli sporigeni aerobi ed anerobi. In: MICROBIOLOGIA FARMACEUTICA 104
SENSITIVITY TO AUGMENTIN OF ANEROBIC BACTERIA BETA-LACTAMASES PRODUCING. 102
Effect of a broad-spectrum cephalosporin on the oral and intestinal microflora in patients undergoing colorectal surgery 102
Aztreonam versus gentamicin in short-term prophylaxis in biliary and gastric surgery 102
Antibiotic susceptibility of bacterial isolates from probiotic products available in Italy 102
Attività antibatterica di cefprozil nei confronti di Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis e Streptococcus pneumoniae circolanti attualmente in Italia 101
Antimicrobial susceptibility of anaerobic and facultative aerobic bacteria isolated from pus specimens of orofacial infections and beta-lactamase production 101
Antimicrobial susceptibility of strains of Enterobacteriaceae isolated from bloodstream infections using current CLSI and EUCAST breakpoints 100
Isolation and characterization of promising probiotic lactobacilli and bifidobacteria from stools of breast-fed infants and honeybees’ gut 99
Antibiotic susceptibility of bacterial isolates from probiotic products available in Italy 98
Antibacterial activity of moxifloxacin against pathogens related with respiratory tract infections 96
Epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated from 2001 to 2005 in Catania 95
DIMINUITA PRESENZA DI FATTORI DI VIRULENZA IN ESCHERICHIA COLI UROPATOGENI ANTIBIOTICO-RESISTENTI 95
Reactivity of 3-aryl-4-amino-5-mercapto-4H-1,2,4-triazoles: synthesis and biological evaluation of 3,6-diaryl derivatives of 7H-1,2,4-thiazole[3,4-b][1,3,4]thiadiazines, of 3-aryl-4-amino-5-carboxymethylthio-4H-1,2,4-triazoles 94
Growth and adhesion to HT-29 cells inhibition of gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination 94
Synthesis of 1-aroyl-4H(R)-thiosemicarbazides, the corresponding 5-aryl 4H(R)-1,2,4-triazolin-3-thiones and some derivatives of pharmaceutical interest 93
Parodontopatia dell'adulto: 3 terapie a confronto 93
Synthesis and antimicrobial evaluation of 4-phenyl-3-isoquinolinoyl-hydrazones 92
Studio microbiologico dell’attività antibatterica “in vivo” della disinfezione “one stage full mouth” con clorexidina nella terapia della parodontite dell’adulto 91
Meccanismi patogenetici di ceppi di Prevotella intermedia e Fusobacterium nucleatum isolati da parodontopatie e da infezioni polmonari 91
Antimicrobial activity and postantibiotic effect of flurithromycin against Helicobacter pylori strains 91
Synthesis and preliminary biological investigation of 2,6-diaryl substituted imidazo(1,2-b)-1,3-4-thiadiazoles [SINTES]I E VALUTAZIONE BIOLOGICA PRELIMINARE DI IMIDAZO[2,1-b]-1,3,4-TIADIAZOLI-2,6-DIARILSOSTITUITI 90
Streptococcus pyogenes emm types and subtypes of isolates from paediatric asymptomatic carriers and children with pharyngitis 90
Bactericidal activity and postantibiotic effect of cefdnir (ci 983, fk 482) against selected athogens 90
Uso di prebiotici e probiotici ed ecosistema microbico intestinale 89
Microbiological characteristics of kanendomycin [Caratteristiche microbiologiche della kanendomicina] 89
Identification and characterization of Lactobacillus paracasei strain with probiotic properties isolated from faeces of healthy adult volunteers 89
Dental implants with locking taper connection versus screwed connection: microbiologic and scanning electron microscope study 88
Colorectal surgery: short-term prophylaxis with clindamycin plus aztreonam or gentamicin 88
Synthesis, spectral behaviour and microbiological properties of some di(nitrothienyl)sulfides. 88
Microbiological intraoperative results in short-term prophylaxis (aztreonam or gentamicin) in abdominal surgery 88
Osservatorio Epidemiologico Italiano: analisi del secondo anno di monitoraggio delle resistenze agli antibiotici in Haemophilus influenzae e Haemophilus parainfluenzae 87
Bactericidal kinetics and postantibiotic effect of Ciprofloxacin against B. catarrhalis, H. influenzae and S. pneumoniae 86
In vitro activity and clinical efficacy of ciprofloxacin in otorhinolaryngeal infections 86
Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production 86
Complete Genome Sequence of Bifidobacterium longum W11 (LMG P-21586), Used as a Probiotic Strain 86
Intercellular communication during yeast cell growth 85
Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy 85
Probiotics:overview of microbiological and immunological characteristics 85
SURGICAL SITE INFECTION IN ELDERLY PATIENTS 84
Predictive value of bacterial analysis of laparotomy wounds 84
Osservatorio Epidemiologico Italiano. Patogeni respiratori comunitari e nosocomiali: analisi delle resistenze nel 1997. Haemophilus influenzae, Haemophilus parainfluenzae e Moraxella catarrhalis 83
Probiotici e Prebiotici:dalla ricerca al consumatore 83
Bacteriological findings and antimicrobial resistance in odontogenic and non odontogenic chronic maxillary sinusitis 82
Incidence of non-fermenting gram-negative bacilli in infected patients 82
Prevenzione e controllo delle infezioni in chirurgia gastrica 82
Caratterizzazione molecolare di ceppi di Lactobacillus spp. utilizzati in prodotti probiotici vaginali e determinazione della sensibilità agli antibiotici 82
Susceptibility of clinical isolates of Haemophilus to new 4-quinolones 81
CT findings in hepatic involvement by Echinococcus granulosus 81
Aztreonam versus gentamicin for short-term prophylaxis in biliary and gastric surgery 80
PRODUZIONE DI B-LATTAMASI ED ANTIBIOTICO SENSIBILITA’ DI GERMI ANAEROBI. 80
Immunizzazione passiva naturale e artificiale. In: MICROBIOLOGIA FARMACEUTICA 80
Caratteristiche microbiologiche e terapeutiche dei batteri probiotici 79
Effetto prebiotico di Opuntia ficus-indica (L.) nei confronti di alcuni ceppi di Lactobacillus e Bifidobacterium isolati da prodotti probiotici farmaceutici 79
SUSCEPTIBILITY OF CLINICAL ISOLATES OF ENTEROBACTERIACEAE TO CEFDINIR (CI 983, FK 482) 78
Evaluation of the antibacterial effect of cefsulodin against Pseudomonadaceae [Valutazione dell'attività antibatterica del cefsulodin nei confronti di Pseudomonadaceae] 78
Correlations between bacterial flora present in the juice and the gastric mucosa and the risk of postoperative infection [Correlazione tra flora batterica presente nel succo e nella mucosa gastrica e rischio di infezione postoperatoria] 77
Studio microbiologico dell'attività "in vivo"della disinfezione "one stage full mouth"con clorexidina nella terapia della parodontite dell'adulto 77
Virulence factors and antibiotic resistance in uropathogenic Escherichia coli 77
L'ambiente intestinale e la disbiosi 77
Impianti dentali a connessione conometrica versus impianti dentali a connessione avvitata:studio microbiologico e al microscopio elettronico a scansione 76
Antimycotic effect of diaryl sulfides with open chains and ring systems containing pyridine and thiadiazole units [Azione antimicotica di alcuni diaril solfuri a catena aperta e ciclici contenenti unità piridiniche e tiadiazoliche] 76
Susceptibility of molecularly characterizeted hospital-associated methicillin-resistant Staphylococcus aureus isolates to dalbavancin 76
Batteri anaerobi non sporigeni (cap. 38) 76
In vitro activity of imipenem towards gram-negative bacilli 75
Microbiological evaluation of 6-beta-amidino-penicillanic acid (mecillinam) 74
Microbiological characteristics of the probiotic strains B. longum BB536 and L. rhamnosus HN001 used in combination 74
Incidence of fermentative and non-fermentative gram-negative bacilli in an intensive care environment [Incidenza di bacilli gram-negativi fermentanti e non fermentanti in ambiente nosocomiale di terapia intensiva] 73
Internalization–associated proteins among Streptococcus pyogenes isolated from asymptomatic carriers and children with pharyngitis 72
Incidence and antibiotic-resistance of gram-negative species isolated from burns [Incidenza antibiotico-resistenza di specie batteriche gram-negative isolate in ustionati] 71
In vitro susceptibility of Arcobacter butzleri and Arcobacter cryaerophilus to different antimicrobial agents 71
L'ofloxacin nel trattamento delle infezioni alte vie respiratorie 69
Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin 69
Epidemiology of antibiotic resistance in human isolates of Enterobacteriaceae in Sicily 68
Totale 10.356
Categoria #
all - tutte 46.526
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.526


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021606 0 0 0 0 0 46 157 15 143 17 173 55
2021/20221.369 195 182 13 33 205 8 198 43 158 3 54 277
2022/20231.899 187 60 26 131 243 339 13 299 506 23 56 16
2023/2024796 49 115 39 66 36 78 29 60 23 48 162 91
2024/20253.111 39 480 198 144 780 267 32 121 244 320 186 300
2025/20264.602 434 394 1.395 384 969 1.026 0 0 0 0 0 0
Totale 15.030